MedTrace Logo

PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma

NCT05565898 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-11-01

No results posted yet for this study

Summary

lymphoma is a common malignancy in the developed world. the two main categories of lymphoma are non-Hodgkin lymphoma and non-Hodgkin lymphoma. Bone marrow biopsy (BMB) is the most direct method of detecting lymphoma infiltration, however it is an invasive procedure. 18 fluro-2deoxy-D glucose PET/CT is a non-invasive examination that can comperhensively evaluate the state of bone marrow (BM) with extremely high sensitivity in detecting bone marrow infiltration of lymphoma.

Conditions

Interventions

DEVICE

positron emission tomography for exclusion of bone marrow infiltration in lymphoma

compare the diagnostic accuracy of PET/CT scan against Bone Marrow Biopsy in detection of bone marrow involvement for staging of lymphoma

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Taha Z. Mohran, M.D · Assiut university- Faculty of Medicine-Department of Clinical Oncology and Nuclear Medicine

  • Nahla M Mahmoud, M.D · Assiut university- Faculty of Medicine-Department of Clinical Oncology and Nuclear Medicine

  • Maha Kh Mahmoud, M.D · Assiut university- Faculty of Medicine-Department of Clinical Oncology and Nuclear Medicine

Eligibility

Min Age
1 Year
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2024-11-30
Completion
2025-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05565898 on ClinicalTrials.gov